NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults

Clint S. Schmidt(NovaDigm Therapeutics (United States)), C. J. White, Ashraf S. Ibrahim(University of California, Los Angeles), Scott G. Filler(University of California, Los Angeles), Yue Fu(University of California, Los Angeles), Michael R. Yeaman(University of California, Los Angeles), John E. Edwards(University of California, Los Angeles), John P. Hennessey(NovaDigm Therapeutics (United States))
Vaccine
October 22, 2012
10.1016/j.vaccine.2012.10.038
Cited by 224

Abstract

Related Papers

No related papers found

Powered by citation graph analysis